Is market access, in the UK, being hindered by its price watchdog, The National Institute for Health and Care Excellence (NICE)? Even after recommending a new treatment, it often takes between 9-12 months before the patient can access it! But does it really need reform? Or is it possible to have pharma and NICE come together, work together and solve this problem? Read more here. (Source: Pharmafile, 8/26/14).
You are here: / / How Big A Problem Is Market Access In The UK?